Abbott (ABT) Tops Q1 EPS by 5c, FY Guidance Unchanged
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq on track for record closing highs as focus turns to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Abbott Labs (ABT) PT Raised to $52 at Barclays Following 1Q Report
April 20, 2017 9:09 AM EDTBarclays raised its price target on Abbott Labs (NYSE: ABT) to $52.00 (from $50.00) while maintaining a Overweight rating. ABT reported 1Q... More



